203 related articles for article (PubMed ID: 10636865)
1. beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter.
Ganapathy ME; Huang W; Rajan DP; Carter AL; Sugawara M; Iseki K; Leibach FH; Ganapathy V
J Biol Chem; 2000 Jan; 275(3):1699-707. PubMed ID: 10636865
[TBL] [Abstract][Full Text] [Related]
2. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
Wu X; Huang W; Prasad PD; Seth P; Rajan DP; Leibach FH; Chen J; Conway SJ; Ganapathy V
J Pharmacol Exp Ther; 1999 Sep; 290(3):1482-92. PubMed ID: 10454528
[TBL] [Abstract][Full Text] [Related]
3. Carnitine/organic cation transporter OCTN2 (Slc22a5) is responsible for renal secretion of cephaloridine in mice.
Kano T; Kato Y; Ito K; Ogihara T; Kubo Y; Tsuji A
Drug Metab Dispos; 2009 May; 37(5):1009-16. PubMed ID: 19220985
[TBL] [Abstract][Full Text] [Related]
4. Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function.
Seth P; Wu X; Huang W; Leibach FH; Ganapathy V
J Biol Chem; 1999 Nov; 274(47):33388-92. PubMed ID: 10559218
[TBL] [Abstract][Full Text] [Related]
5. Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney.
Tamai I; China K; Sai Y; Kobayashi D; Nezu J; Kawahara E; Tsuji A
Biochim Biophys Acta; 2001 Jun; 1512(2):273-84. PubMed ID: 11406104
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier.
Friedrich A; Prasad PD; Freyer D; Ganapathy V; Brust P
Brain Res; 2003 Apr; 968(1):69-79. PubMed ID: 12644265
[TBL] [Abstract][Full Text] [Related]
7. Acute administration of cefepime lowers L-carnitine concentrations in early lactation stage rat milk.
Ling B; Alcorn J
J Nutr; 2008 Jul; 138(7):1317-22. PubMed ID: 18567754
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine residues affecting sodium stimulation of carnitine transport in the OCTN2 carnitine/organic cation transporter.
Amat di San Filippo C; Longo N
J Biol Chem; 2004 Feb; 279(8):7247-53. PubMed ID: 14665638
[TBL] [Abstract][Full Text] [Related]
9. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
[TBL] [Abstract][Full Text] [Related]
10. Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Ohashi R; Tamai I; Yabuuchi H; Nezu JI; Oku A; Sai Y; Shimane M; Tsuji A
J Pharmacol Exp Ther; 1999 Nov; 291(2):778-84. PubMed ID: 10525100
[TBL] [Abstract][Full Text] [Related]
11. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier.
Kido Y; Tamai I; Ohnari A; Sai Y; Kagami T; Nezu J; Nikaido H; Hashimoto N; Asano M; Tsuji A
J Neurochem; 2001 Dec; 79(5):959-69. PubMed ID: 11739607
[TBL] [Abstract][Full Text] [Related]
12. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.
Tamai I; Ohashi R; Nezu J; Yabuuchi H; Oku A; Shimane M; Sai Y; Tsuji A
J Biol Chem; 1998 Aug; 273(32):20378-82. PubMed ID: 9685390
[TBL] [Abstract][Full Text] [Related]
13. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.
Ohashi R; Tamai I; Nezu Ji J; Nikaido H; Hashimoto N; Oku A; Sai Y; Shimane M; Tsuji A
Mol Pharmacol; 2001 Feb; 59(2):358-66. PubMed ID: 11160873
[TBL] [Abstract][Full Text] [Related]
14. Quantitative structure activity relationship for inhibition of human organic cation/carnitine transporter.
Diao L; Ekins S; Polli JE
Mol Pharm; 2010 Dec; 7(6):2120-31. PubMed ID: 20831193
[TBL] [Abstract][Full Text] [Related]
15. Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2.
Wagner CA; Lükewille U; Kaltenbach S; Moschen I; Bröer A; Risler T; Bröer S; Lang F
Am J Physiol Renal Physiol; 2000 Sep; 279(3):F584-91. PubMed ID: 10966938
[TBL] [Abstract][Full Text] [Related]
16. The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
Jariyawat S; Sekine T; Takeda M; Apiwattanakul N; Kanai Y; Sophasan S; Endou H
J Pharmacol Exp Ther; 1999 Aug; 290(2):672-7. PubMed ID: 10411577
[TBL] [Abstract][Full Text] [Related]
17. [Biopharmaceutical studies on molecular mechanisms of membrane transport].
Tsuji A
Yakugaku Zasshi; 2002 Dec; 122(12):1037-58. PubMed ID: 12510384
[TBL] [Abstract][Full Text] [Related]
18. Functional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiency.
Amat di San Filippo C; Wang Y; Longo N
J Biol Chem; 2003 Nov; 278(48):47776-84. PubMed ID: 14506273
[TBL] [Abstract][Full Text] [Related]
19. Colistin is substrate of the carnitine/organic cation transporter 2 (OCTN2, SLC22A5).
Visentin M; Gai Z; Torozi A; Hiller C; Kullak-Ublick GA
Drug Metab Dispos; 2017 Dec; 45(12):1240-1244. PubMed ID: 28986476
[TBL] [Abstract][Full Text] [Related]
20. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart.
Iwata D; Kato Y; Wakayama T; Sai Y; Kubo Y; Iseki S; Tsuji A
Drug Metab Pharmacokinet; 2008; 23(3):207-15. PubMed ID: 18574325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
